Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,520 | -26,271 | -24,623 | -31,292 | -24,862 |
| Depreciation Amortization | 7,518 | 4,779 | 2,151 | 3,407 | 1,956 |
| Income taxes - deferred | -1,839 | -1,839 | 123 | -8,736 | 0 |
| Accounts receivable | -5,678 | -5,628 | -2,725 | -4,631 | -6,087 |
| Accounts payable and accrued liabilities | 2,155 | 302 | 187 | -182 | 673 |
| Other Working Capital | -3,411 | -6,505 | -10,074 | -4,102 | -8,086 |
| Other Operating Activity | 12,120 | 4,731 | 13,531 | 26,553 | 20,204 |
| Operating Cash Flow | $-35,655 | $-30,431 | $-21,430 | $-18,983 | $-16,202 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -131,808 | 0 | N/A | N/A | N/A |
| PPE Investments | -3,836 | -1,799 | -402 | -3,473 | -2,584 |
| Net Acquisitions | -26,419 | -26,114 | N/A | -63,184 | -33,184 |
| Investing Cash Flow | $-162,063 | $-27,913 | $-402 | $-66,657 | $-35,768 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -88 | -55 | -24 | -8 | 0 |
| Common Stock Issued | 2,487 | 2,020 | 1,296 | 6,546 | 5,631 |
| Other Financing Activity | -134 | -88 | -56 | -1,117 | -336 |
| Financing Cash Flow | $2,265 | $1,877 | $1,216 | $5,421 | $5,295 |
| Beginning Cash Position | 329,633 | 329,633 | 329,633 | 409,852 | 409,852 |
| End Cash Position | 134,180 | 273,166 | 309,017 | 329,633 | 363,177 |
| Net Cash Flow | $-195,453 | $-56,467 | $-20,616 | $-80,219 | $-46,675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,655 | -30,431 | -21,430 | -18,983 | -16,202 |
| Capital Expenditure | -3,845 | -1,807 | -402 | -3,483 | -2,590 |
| Free Cash Flow | -39,500 | -32,238 | -21,832 | -22,466 | -18,792 |